SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001521536-13-000920
Filing Date
2013-11-13
Accepted
2013-11-13 07:23:56
Documents
2
Period of Report
2013-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1101322_8k-biozone.htm 8-K 25469
2 ASSET PURCHASE AGREEMENT q1101322_ex2-1.htm EX-2.1 370919
  Complete submission text file 0001521536-13-000920.txt   397624
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 131212502
SIC: 2834 Pharmaceutical Preparations